Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Mexico Nac AutonomafiledCriticalUniv Mexico Nac Autonoma
Priority to MX2018003438ApriorityCriticalpatent/MX2018003438A/en
Publication of MX2018003438ApublicationCriticalpatent/MX2018003438A/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
The present invention relates to a pharmaceutical formulation to repair and/or regenerate tooth enamel with some defect or demineralization of the dental surface, using an inducing peptide in the formation of hydroxyapatite crystals with artificial saliva as a physiologically acceptable vehicle. The enamel is in contact with a solution containing a peptide and a buffer at a certain pH, promoting the formation of said crystals in the demineralized areas of the enamel and/or underlying dentin, which have lost their structure, regenerating de novo enamel and occluding dentinal tubules.
A randomised clinical trial to assess maintenance of gingival health by a novel gel to foam dentifrice containing 0.1% w/wo‐cymen‐5‐ol, 0.6% w/w zinc chloride
Shear bond strength of composite to primary enamel treated with casein phosphopeptide amorphous calcium phosphate using total-etch and self-etch bonding systems